Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-064585
Filing Date
2011-11-14
Accepted
2011-11-14 17:09:16
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v238261_10q.htm 10-Q 770617
2 EXHIBIT 31.1 v238261_ex31-1.htm EX-31.1 10518
3 EXHIBIT 31.2 v238261_ex31-2.htm EX-31.2 10478
4 EXHIBIT 32.1 v238261_ex32-1.htm EX-32.1 5242
5 EXHIBIT 32.2 v238261_ex32-2.htm EX-32.2 5016
  Complete submission text file 0001144204-11-064585.txt   2698280

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptbg-20110930.xml EX-101.INS 352991
7 XBRL TAXONOMY EXTENSION SCHEMA ptbg-20110930.xsd EX-101.SCH 18330
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptbg-20110930_cal.xml EX-101.CAL 24905
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptbg-20110930_def.xml EX-101.DEF 68600
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptbg-20110930_lab.xml EX-101.LAB 154166
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptbg-20110930_pre.xml EX-101.PRE 91777
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51474 | Film No.: 111204228
SIC: 2834 Pharmaceutical Preparations